Literature DB >> 32798483

Interference in scientific research on COVID-19 in Turkey.

Hasan Bayram1, Nurdan Köktürk2, Osman Elbek2, Oğuz Kılınç2, Abdullah Sayıner2, Elif Dağlı2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32798483      PMCID: PMC7426099          DOI: 10.1016/S0140-6736(20)31691-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as it was later named, was first identified in Wuhan, China, on Jan 7, 2020. Over the following months, the virus rapidly spread throughout the world. The disease, COVID-19, was characterised as a pandemic by WHO on March 11, 2020. On the same day, the Turkish Ministry of Health reported the first case in Turkey. According to the Global Initiative on Sharing All Influenza Data platform, which analyses the genomic epidemiology of SARS-CoV-2, the disease reached Turkey mainly through Iran, with whom Turkey has strong commercial and touristic ties, and Saudi Arabia, where thousands of Turkish citizens travelled to visit the holy places until mid-March, 2020. 2 months after the first case, on May 11, 2020, the Turkish Ministry of Health declared that the number of COVID-19 cases had reached 139 771, with 3841 deaths. However, the excess mortality for Istanbul alone during this period was 4209 deaths. From 2016–19, the average number of deaths that occurred in Istanbul was 23 232 for the period of March 11 to July 5. In 2020, this figure went up to 27 955 deaths. The excess mortality found between March 11 and July 5, 2020, in Istanbul was 4723 deaths. There were at least 1952 unexplained deaths. However, the officially reported COVID-19 mortality in the same period was 2771 deaths. Because no other serious mass health events were recorded at that time, this discrepancy could be explained by non-compliance with WHO codes from the International Classification of Diseases (tenth edition). The official reporting system of Turkey only covered PCR-positive cases. As of July 27, 2020, Turkey ranks fourth in the European region for cases of COVID-19, with a total number of 225 173 patients and 5596 COVID-19 deaths, as reported by the Ministry of Health on the basis of PCR-positive cases alone. The establishment of a scientific board and full coverage of treatment, and the encouragement of research by the Ministry of Health and funding bodies such as the Scientific and Technological Research Council of Turkey and the Health Institutes of Turkey were admirable steps taken by the authorities in the beginning of the pandemic. However, tension soon started building among the public sector and medical and scientific organisations due to the Ministry of Health's lack of transparency, its reluctance to share basic data, and its refusal to collaborate. There were also concerns about the shortage of personal protective equipment for health-care workers. The final stroke came with the control of COVID-19 research by the Ministry of Health. Despite the great interest in research on COVID-19 in Turkey by researchers and physicians, the Turkish Ministry of Health announced a mandatory application for permission for research on COVID-19, before any application is made to ethics committees. This unprecedented decision was against the Constitution and laws regulating research activities in Turkey. It appears that most submitted projects have been approved by the Ministry of Health, but some projects, including a large, multicentre observational study by the Turkish Thoracic Society, have been rejected without any clear explanation. The regular procedure for research activities in Turkey is well defined. In keeping with the international regulations, researchers must get approval from the independent ethics committee. The Turkish Constitution clearly states that “everyone can learn science and art freely and has the right to teach, explain, disseminate and research in these areas”. The Science Academy, a member of the International Science Council, has highlighted this fact. The Turkish Medical Association and other professional medical organisations made a declaration through a press conference and urged the Ministry of Health to cancel their decision. In conclusion, we, as respiratory physicians and scientists, are worried about the restrictions imposed by the Turkish Ministry of Health on independent research about the COVID-19 pandemic in Turkey, and we sincerely hope that the Ministry of Health's decision will be taken back in compliance with the Turkish Constitution.
  5 in total

1.  The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.

Authors:  Nurdan Kokturk; Cenk Babayigit; Seval Kul; Pelin Duru Cetinkaya; Sibel Atis Nayci; Serap Argun Baris; Oguz Karcioglu; Pinar Aysert; Ilim Irmak; Aycan Akbas Yuksel; Yonca Sekibag; Oya Baydar Toprak; Emel Azak; Sait Mulamahmutoglu; Caglar Cuhadaroglu; Aslihan Demirel; Bugra Kerget; Burcu Baran Ketencioglu; Hasan Selcuk Ozger; Gulcihan Ozkan; Zeynep Ture; Begum Ergan; Vildan Avkan Oguz; Oguz Kilinc; Merve Ercelik; Tansu Ulukavak Ciftci; Ozlem Alici; Esra Nurlu Temel; Ozlem Ataoglu; Asena Aydin; Dilek Cetiner Bahcetepe; Yusuf Taha Gullu; Fusun Fakili; Figen Deveci; Neslihan Kose; Muge Meltem Tor; Gulsah Gunluoglu; Sedat Altin; Teyfik Turgut; Tibel Tuna; Onder Ozturk; Oner Dikensoy; Pinar Yildiz Gulhan; Ilknur Basyigit; Hasim Boyaci; I Kivilcim Oguzulgen; Sermin Borekci; Bilun Gemicioglu; Firat Bayraktar; Osman Elbek; Ismail Hanta; Hacer Kuzu Okur; Gulseren Sagcan; Oguz Uzun; Metin Akgun; Goksel Altinisik; Berna Dursun; Ebru Cakir Edis; Erkmen Gulhan; Fusun Oner Eyuboglu; Okkes Gultekin; Yavuz Havlucu; Metin Ozkan; Aysin Sakar Coskun; Abdullah Sayiner; Ali Fuat Kalyoncu; Oya Itil; Hasan Bayram
Journal:  Respir Med       Date:  2021-04-28       Impact factor: 3.415

Review 2.  Novel coronavirus pathogen in humans and animals: an overview on its social impact, economic impact, and potential treatments.

Authors:  Rokeya Akter; Md Habibur Rahman; Tanima Bhattacharya; Deepak Kaushik; Vineet Mittal; Jatin Parashar; Kuldeep Kumar; Md Tanvir Kabir; Priti Tagde
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-18       Impact factor: 4.223

3.  Existence of SARS-CoV-2 RNA on ambient particulate matter samples: A nationwide study in Turkey.

Authors:  Özgecan Kayalar; Akif Arı; Gizem Babuççu; Nur Konyalılar; Özlem Doğan; Füsun Can; Ülkü A Şahin; Eftade O Gaga; S Levent Kuzu; Pelin Ertürk Arı; Mustafa Odabaşı; Yücel Taşdemir; S Sıddık Cindoruk; Fatma Esen; Egemen Sakın; Burak Çalışkan; Lokman H Tecer; Merve Fıçıcı; Ahmet Altın; Burcu Onat; Coşkun Ayvaz; Burcu Uzun; Arslan Saral; Tuncay Döğeroğlu; Semra Malkoç; Özlem Özden Üzmez; Fatma Kunt; Senar Aydın; Melik Kara; Barış Yaman; Güray Doğan; Bihter Olgun; Ebru N Dokumacı; Gülen Güllü; Elif S Uzunpınar; Hasan Bayram
Journal:  Sci Total Environ       Date:  2021-05-25       Impact factor: 7.963

4.  COVID-19 transmission sources, management, and scientific research in Turkey.

Authors:  Fatih Kahraman; Adem Özkara
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

5.  Promotion of scientific research on COVID-19 in Turkey.

Authors:  Fahrettin Koca
Journal:  Lancet       Date:  2020-09-03       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.